University of Maryland, Baltimore

Why trials sponsored by University of Maryland, Baltimore stopped, in this sample of ClinicalTrials.gov.

17 stopped trials with a clear reason; 100% ended for non-scientific reasons.

Trials

• 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML
  NCT06626633 · SUSPENDED · funding business
  “Pharmaceutical Company withdrew support and investigational product”
• Macitentan to Prevent PRVO
  NCT05946811 · WITHDRAWN · funding business
  “Study was cancelled by funding agency before starting enrollment.”
• Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
  NCT05142228 · TERMINATED · slow accrual
  “Low enrollment rate”
• Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
  NCT04896658 · TERMINATED · slow accrual
  “The study was terminated due to FDA withdrawal of the drug and lack of enrollment with available BCMA therapies that were deemed safer.”
• Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder
  NCT04169360 · WITHDRAWN · funding business
  “The FDA determined that there is not adequate safety information to continue clinical investigations using ANS-6637 and Amygdala Neurosciences, the product company of ANS-6637, is no longer pursuing research with this compound.”
• Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes
  NCT03631654 · WITHDRAWN · funding business
  “Unable to obtain funding”
• Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)
  NCT04415476 · WITHDRAWN · regulatory
  “Study did not proceed to IRB approval.”
• HIV-1 and Brain Interaction on Smoking Comorbidity
  NCT03308331 · WITHDRAWN · logistics pi
  “We originally had a collaboration with a PI but he has left the University.”
• Antioxidant Use in Diabetes to Reduce Oxidative Stress
  NCT03056014 · TERMINATED · logistics pi
  “COVID”
• GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
  NCT02095184 · TERMINATED · slow accrual
  “This study was terminated due to slow accrual, and this due to the changing practice patterns, and difficulties with insurance coverage for some of the study related tests, such as OncotypeDx.”
• A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
  NCT01954524 · TERMINATED · funding business
  “The study is closed due to lack of funding to support the study.”
• Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
  NCT01925573 · TERMINATED · slow accrual
  “Poor accrual”
• 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
  NCT02000596 · TERMINATED · funding business
  “funding withdrawn by sponsor”
• Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
  NCT01234532 · TERMINATED · slow accrual
  “low accrual”
• Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
  NCT00732147 · WITHDRAWN · funding business
  “Sponsor could not fund.”
• Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
  NCT00755950 · TERMINATED · slow accrual
  “Low enrollment”
• Renal Effects of Intrarenal Nesiritide
  NCT00270829 · TERMINATED · funding business
  “Funding not available”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.